Product Name: BI-1356 (Linagliptin) | DPP-IV/DPP-4 inhibitor
Product Description: BI-1356 (Linagliptin) is a highly potent and selective dipeptidyl peptidase 4 (DPP-4) inhibitor (IC50 = 1 nM) for treatment of type II diabetes. [1] BI-1356 can increase incretin levels (GLP-1 and GIP), which increases insulin secretion and inhibits glucaWeb Site click
Chemical Formula: C25H28N8O2
Molecular Weight: 472.54
‘&“CAS NO: 1341224-83-6 PF-4136309
Purity: 98%
Appearance: White
Chemical Name: (R)-8-(3-aminopiperidin-1-yl)-7-(but-2-ynyl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dionePotassium Channel inhibitors
Solubility: Up to 25 mM in DMSO
Shipping Condition: The product is shipped in a glass vial at ambient temperature.
Storage Condition: For longer shelf life, store solid powder or DMSO solution at -20oC desiccated.PubMed ID:http://pubs.acs.org/doi/abs/10.1021/jm800180e
